1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
Date of Report (Date of earliest event reported) October 3, 1995
MEDEX, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Ohio 0-9042 31-4441680
- --------------------------------------------------------------------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
3637 Lacon Road Hilliard, Ohio 43026
- --------------------------------------------------------------------------------
(Address or principal executive offices) (Zip Code)
Registrant's telephone number, including area code (614) 876-2413
Not Applicable
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
2
Item 5. Other Events
A. Medex, Inc. has publicly announced that Mr. Bradley P. Gould has been
elected Chief Executive Officer of the Company by the Board of Directors,
effective immediately.
Mr. Gould succeeds Phillip D. Messinger who had served as CEO since March,
1993 and becomes Vice Chairman of the Board.
Mr. Gould, who joined the Company in 1985, had been serving as Senior Vice
President of European Operations.
B. Additionally, the Company announced that Mr. Michael J. Barilla has
been named acting Chief Financial Officer succeeding Donald H. Barry who
has left the Company after serving as Chief Financial Officer and
Treasurer since October of 1993. Mr. Kevin L. Barnett was named to
replace Mr. Barry as Treasurer.
Mr. Barilla, who was serving as Vice President, Internal Auditing at the
time of his appointment has served in a number of operational and
administrative positions, including Corporate Controller during his 12
years with the Company.
Mr. Barnett, who joined the Company in 1992 as Assistant Treasurer, has
served as Vice President and Corporate Controller since May of 1994.
Item 7. Financial Statements and Exhibits
None
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDEX, INC.
(Registrant)
Dated: October 9, 1995 By /s/ Bradley P. Gould
------------------------------
Bradley P. Gould,
Chief Executive Officer